Showing results (141-150 of 196) with videos related to
Sort By:
Pageof 20
Trials|December 31, 2015
Exploring the role and function of trial steering committees: results of an expert panel meetingNicola L Harman, Elizabeth J Conroy, Steff C Lewis, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2010
Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyMartin J Landray, Jonathan R Emberson, Lisa Blackwell, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.Thrombosis and Haemostasis|March 1, 2013
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.Journal of the American College of Cardiology|April 14, 2012
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paperRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.Blood|December 9, 2004
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyGuido Finazzi, Vanesa Caruso, Roberto Marchioli, et al.Circulation|July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney DiseaseRichard Haynes, Parminder K Judge, Natalie Staplin, et al.Thrombosis and Haemostasis|November 15, 2013
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.Kidney International|July 3, 2014
The 2014International Workshop on Alport SyndromeJeffrey H Miner, Colin Baigent, Frances Flinter, et al.Pageof 20